Bendamustine, Low-dose dexamethasone, and lenalidomide (BdL) for the treatment of patients with relapsed/refractory multiple myeloma confirms very promising results in a phase I/II study.
| Image |  |
|---|---|
| Description | scientific article published on 21 July 2016 |
| Author/s |
author: Attilio Guarini Pellegrino Musto Antonio Palumbo Massimo Gentile Alessia Bari Fortunato Morabito Samantha Pozzi Giuseppe Mele Roberto Ria Carla Minoia |
| Publication date | July 21, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |